Skip to main content

Peer Review reports

From: Injections frequency and health care costs in patients treated with aflibercept compared to ranibizumab: new real-life evidence from Switzerland

Original Submission
16 Mar 2017 Submitted Original manuscript
27 Apr 2017 Reviewed Reviewer Report - Souska Zandi
16 Jul 2017 Author responded Author comments - Oliver Reich
Resubmission - Version 2
16 Jul 2017 Submitted Manuscript version 2
3 Aug 2017 Reviewed Reviewer Report - Souska Zandi
21 Aug 2017 Author responded Author comments - Oliver Reich
Resubmission - Version 3
21 Aug 2017 Submitted Manuscript version 3
30 Aug 2017 Author responded Author comments - Oliver Reich
Resubmission - Version 4
30 Aug 2017 Submitted Manuscript version 4
28 Sep 2017 Author responded Author comments - Oliver Reich
Resubmission - Version 5
28 Sep 2017 Submitted Manuscript version 5
Publishing
19 Nov 2017 Editorially accepted
4 Dec 2017 Article published 10.1186/s12886-017-0617-x

You can find further information about peer review here.

Back to article page